Tagged with ISS

Pharma Axel B. Müller, managing director of Intergenerika, the Swiss generics association, reveals the penetration rate of generics in Switzerland; why generics are a safe, and smarter choice, manufactured to modern standards with affordable prices; and the threat of government forcing generic companies to benchmark their prices to nine European countries…

Pharma Outspoken Italian Managing Director of Israeli-based Teva, Hubert Puech d’Alissac, talks about his passion for social responsibility, adapting to the new realities of patient care in the digital age, and his aspirations for the “Made in Italy” brand. When we covered Italy in 2009 your predecessor Mr. Walter Medda spoke…

Pharma Ten years after his first interview with Focus Reports, Wafik Bardissi discusses Minapharm’s position as the leading biosimilar manufacturer in the Middle East. Has Egypt taken steps to incentivize the development or registration of biosimilar products? At present, more attention is required in Egypt to promote biosimilar development or encourage the registration of…

Pharma Prof. Walter Ricciardi has just been appointed as the new president for the Italian National Institute of Health (ISS). He explains his priorities since taking office, the crucial role the ISS plays in the NHS and his vision for the future of the Italian National Healthcare System. Prof. Ricciardi, can…

Pharma Alessandra Modenese Kauffmann, General Manager of the Swiss Chamber of Commerce, shares her insights into the relationship between Italy and Switzerland, the Chamber’s efforts to foster trade between the two countries and the opportunities offered through close collaboration between Swiss and Italian companies. Alessandra, the chamber has been active in…

infrastructure Dogan Taşkent, president of the Swiss Chamber of Commerce in Turkey discusses the most successful models for innovation in Turkey, the current status of start-up incubators in the country, and how Turkey can learn from the Swiss model for innovation. What are the main economic challenges that Turkey is facing…

Investissement Québec Investissement Québec is a public corporation whose mission is to contribute to Québec’s economic development. Investissement Québec’s project manager, Stéphanie Murphy, discusses the role and contribution of pharmaceutical companies to Quebec’s economic landscape and the challenges associated with promoting Quebec as an attractive place for FDI. What are some of…

SWISSE Speaking to the Australian environment, how would you rate the market in terms of companies like Swisse? After traveling the world, the Australian market has shown to be one of the most developed and competitive we have seen. Pharmacies stock endless product options, and because of that, brands really need…

Overseas Compatriot Affairs Commission Minister Wu, please tell our readers a little about your background, and how you came to be in charge of the Overseas Compatriot Affairs Commission (OCAC). I graduated from National Taiwan University and did two years service in the Veterans General Hospital as a surgeon. I moved to the United…